Carbohydrate source and bifidobacteria influence the growth of Clostridium perfringens in vivo and in vitro

Nutrition Research

Volumn 18, Issue 11, 1998, Pages 1889-1897

  Kullen, Martin J ^a   Khil, Jinmo ^a   Busta, Francis F ^a   Gallaher, Daniel D ^a   Brady, Linda J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bifidobacteria; C. perfringens; Oligosaccharides; Prebiotics; Probiotics; Rats

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CARBOHYDRATE INTAKE; CLOSTRIDIUM PERFRINGENS; CULTURE MEDIUM; GROWTH RATE; INTESTINE FLORA; MALE; MILK; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS A; GLYCINE MAX; MAMMALIA; TRITICUM AESTIVUM;

EID: 0032213542     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(98)00158-4     Document Type: Article

References (32)

1. 1. Moore WEC, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61:3202-3207.
2. 2. De Simone C., Vesely R, Bianchi SB, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993; 9:23-28.
3. 3. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984; 86:174-193.
4. 4. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
5. 5. Hill MJ. Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prevent 1995; 4:353-358.
6. 6. Marsman KE, McBurney MI. Dietary fiber and short-chain fatty acids affect cell proliferation and protein synthesis in isolated rat colonocytes. J Nutr 1996; 126:1429-1437.
7. 7. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108:975-982.
8. 8. Bouhnik Y, Flourie B, Riottot M, Bisetti N, Gailing MF, Guibert A, Bornet F, Rambaud JC. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr Cancer 1996; 26:21-29.
9. 9. Ibrahim SA, Bezkorovainy A. Inhibition of Escherichia coli by bifidobacteria. J Food Protect 1993; 56:713-715.
10. 10. Jiang T, Mustapha A, Savaiano DA. Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum. J Dairy Sci 1996; 79:750-757.
11. 11. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium, inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997; 18:833-841.
12. 12. Bouhnik Y, Pouchart P, Marteau P, Arlet G, Goderel I, Rambaud JC. Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology 1992, 102:875-878.
13. 13. Kullen MJ, Amann, MM, O'Shaughnessy MJ, O'Sullivan DJ, Busta FF, Brady LJ. Differentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J Nutr 1997; 127:89-94.
14. 14. Mangin I, Bourget N, Bouhnik Y, Bisetti N, Simonet JM, Decaris B. Identification of Bifidobacterium strains by rRNA gene restriction patterns. Appl Environ Microbiol 1994; 60:1451-1458.
15. 15. Khil J, Amann M, Brady L, Gallaher D. The effect of bifidobacteria and complex carbohydrate consumption on colonic precancerous lesions. FASEB J 1996; 10:A2852.
16. 16. Isaac S, Jennings D. Microbial culture. Oxford: Bios Scientific Publishers, 1995.
17. 17. Munoa FJ, Pares R. Selective medium for the isolation and enumeration of Bifidobacterium spp. Appl Environ Microbiol 1988; 54:1715-1718.
18. 18. Steele RGD, Torrie JH. Principles and procedures of statistics: a biomedical approach, 2nd ed. New York: McGraw-Hill, 1988.
19. 19. Campbell JM, Fahey Jr. GC, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 1997; 127:130-136.
20. 20. Howard MD, Gordon DT, Garleb KA, Kerley MS. Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J Nutr 1995; 125: 2064-26069.
21. AL. In: Sneath, PH, Nair NS, Sharpe ME, Holt JG, eds. Bergey's Manual of Systematic Bacteriology Vol. 2, 9th ed. Baltimore: The Williams & Wilkins Company, 1986:1141-1200.
22. 22. MacLennon JD. The histotoxic clostridial infections of man. Bacteriol Rev 1962; 26:177-276.
23. 23. Stephenson JR, Wright DJ. Clostridial bacteraemia. J Hosp Infect 1982; 3:311-312.
24. 24. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994; 77:412-420.
25. 25. Matzke M, Tatini SR. Inhibition of gram negative and gram positive pathogens by bifidobacteria. J Dairy Sci 1996; 79: Suppl. 1, D6.
26. 26. Meghrous J, Eulogue P, Junelles AM, Ballongue J, Petitdemange H. Screening of Bifidobacterium strains for bacteriocin production. Biotechnol Lett 1990; 12: 575-580.
27. 27. Yildirim Z, Johnson, MG. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J Food Protect 1998; 61:47-51
28. 28. Molis C, Flourie B, Ouarne F, Gailing MF, Lartigue S, Guibert A, Bornet F, Galmiche JP. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996; 64:324-328.
29. 29. Gibson GR, Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 1994; 118:121-128.
30. 30. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75:373-80.
31. 31. Yazawa K, Tamura Z. Search for sugar sources for selective increase of bifidobacteria. Bifidobacteria Microflora 1982; 1:39-44.
32. 32. Yazawa K, Imai K, Tamura Z. Oligosaccharides and polysaccharides specifically utilizable by bifidobacteria. Chem Pharm Bull 1978; 26:3306-3311.